Incorporated in 1983, Lupin Limited operates as a pharmaceutical company headquartered in Mumbai, India. It focuses on producing, developing, and marketing various branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs) worldwide.
Business Segment
The company’s business segments include:
Geographical Presence
It serves both within and outside India. It engages in trading and related activities, extending its reach to global markets.
Key stock indicators that show how well a company is doing, making it easier to understand its true value and performance.
Strong Outperformer
Somewhat Undervalued
Good Quality
Low Price Fluctuation
Analysts are Very Bullish
Peer comparison lists companies from the same sector, scored and ranked based on Crisp Analysis. It helps understand how a company stands against its competitors.
Shareholding pattern shows how a company’s shares (ownership) are distributed among different shareholding entities like promoters, Foreign Institutional Investors (FIIs), Domestic Institutional Investors (DIIs), and retail investors, among others. Changes in the shareholding pattern can indicate the performance outlook of a stock.
The share price of Lupin Ltd. is ₹2,344.60 on NSE as of 12/3/2026, 2:23:03 am. Share prices may change frequently due to market movements.
The market capitalisation of Lupin Ltd. is ₹1,07,972Cr as of 12/3/2026, 2:23:03 am
The current Price to Earnings (P/E) ratio of Lupin Ltd. is 22.98 as of 12/3/2026, 2:23:03 am
The Price to Book (P/B) ratio of Lupin Ltd. stands at 6.21 as of 12/3/2026, 2:23:03 am
Lupin Ltd. reported an ROE of 20.88% for the last reported financial year on a consolidated account basis.
As of 12/3/2026, 2:23:03 am, Lupin Ltd.’s shareholding pattern is: promoters hold 46.90%, FIIs hold 21.50%, DIIs hold 25.60%, and public shareholders hold 6.00%.
The 52-week high of Lupin Ltd. is ₹2,377.60 and the 52-week low is ₹2,336.50 as of 12/3/2026, 2:23:03 am.
The earnings per share (EPS) of Lupin Ltd. is ₹25.74 for the quarter ended Dec 2025.
The stock symbol of Lupin Ltd. is LUPIN.
You can buy Lupin Ltd. shares by opening a demat and trading account with Share.Market and placing a buy order on NSE or BSE during market hours.
The fair value of Lupin Ltd. depends on factors such as earnings growth, financial performance, and overall market conditions. Investors should assess fundamentals before making investment decisions.
Earnings per share (EPS) measures the profit earned by a company for each of its outstanding shares. Generally, the higher a company’s EPS is, the more profitable it is considered to be.
Also called a profit and loss statement, an income statement shows a company’s income, expenses, and how much profit or loss it has made over a specific accounting period. It provides a clear view of how well the business is running.
A balance sheet is a financial statement that details a company’s assets, liabilities, and shareholders’ equity at a given time. It helps assess how financially strong and stable the company is.
Cash flow highlights the cash or cash equivalents moving in and out of a company during a particular period. It provides a clear picture of how well a company manages its cash by tracking its operating, investing and financing activities.
Pivot analysis uses a special price point, called the pivot point, to show the overall market trend during different periods. This pivot point is the average of the previous day’s high, low, and closing prices of a specific asset.
Note: Support and Resistance level for the day, calculated based on price range of the previous trading day.
Volume analysis tracks how many shares were traded for a specific period. Total traded volume represents the overall number of shares traded, while combined delivery volume indicates only those shares which are delivered (transferred for ownership). Delivered shares indicate long-term investor interest.